Bis zu 90% sparen! Kostenloser Depotgebühren-Check
030-275 77 6400
DAX-1,75 % EUR/USD+0,59 % Gold+1,91 % Öl (Brent)-1,49 %

The Six Stars of the Cannabis Industry in 2019

Nachrichtenquelle: PR Newswire (engl.)
10.07.2019, 14:00  |  1134   |   |   

FN Media Group Presents Safehaven.com Market Commentary

LONDON, July 10, 2019 /PRNewswire/ -- Some are ready to call it quits on cannabis. But the Green Revolution has only just gotten started. The big plays — Canopy Growth Corp, Aurora, Cronos Group — saw big gains in 2017 but slowed down in 2018 and seem to have stalled in 2019. Mentioned in today's commentary includes: OrganiGram Holdings (NASDAQ: OGI) (TSX-V: OGI), CannTrust Holdings Inc. (NYSE: CTST) (TSX: TRST), Aleafia Health Inc (OTCQX: ALEAF) (TSX: ALEF), THC Biomed International (OTCQX: THCBF) (CSE: THC), Cronos Group (NASDAQ: CRON) (TSX: CRON).

Some worry that it's just a big bubble — but they're not looking closely enough. There are plenty of opportunities for investors looking to cash in on the cannabis boom.

From companies out for mega-deals, changing the face of cannabis branding as we know it, to obscure tech plays completely transforming the marijuana supply chain, smart investors know where to look as the industry continues to weed out the weak hands.

Cannabis produced $6 billion in deal value between 2015 and 2018. And that's nothing compared to what's next. Estimates peg the legal cannabis market at $66 billion by 2025. But it could be much, much bigger.

Legislation, from Canada to Uruguay to the United Kingdom, has made cannabis more accessible. But most cannabis consumption is still managed through the illegal market — which could be much, much bigger than the current retail market.

What is happening is quite literally a once-in-a-lifetime investment opportunity. And while a few big names have dominated the conversation, the real profit lies beneath the hype in companies with solid fundamentals, diversified portfolios and a strong vision.

Here are six companies looking to take cannabis mainstream in 2019:

OrganiGram Holdings (NASDAQ: OGI) (TSX-V: OGI)

OrganiGram is a Canadian holdings company looking to take the burgeoning cannabis industry to the next level. With numerous subsidiaries from which it produces and distributes recreational and medical marijuana, OrganiGram is well positioned to ride the next Green Wave into profits.

OrganiGram has carved out its place in cannabis royalty by securing deals across Canada, from Saskatchewan to British Columbia. In addition to its in-person sales strategy, OrganiGram also offers another unique method of distribution. Online and over-the-phone options. More than that, however, OrganiGram and its partners knows how to manage the surging Canadian demand that has left other distributors without product for periods of time.

Diesen Artikel teilen
Seite 1 von 9

Diskussion: Einer der "Cannabis-Werte" 2017 mit Potential auf ein Alleinstellungsmerkmal in seinem Sek

Diskussion: Diskussion zu Cann Trust Holdings
Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.
CannabisFIMarihuanaNASDAQUruguay


1 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Kommentare

Neuste Meldung: aleafia health ist wohl ein verborgener Schatz, der in der nächsten Zeit zu einem Global Player wächst und dann nur noch gehoben werden muss *katsching*🤑

LONDON, July 10, 2019 /PRNewswire/ -- Some are ready to call it quits on cannabis. But the Green Revolution has only just gotten started. The big plays — Canopy Growth Corp, Aurora, Cronos Group — saw big gains in 2017 but slowed down in 2018 and seem to have stalled in 2019. Mentioned in today's commentary includes: OrganiGram Holdings (NASDAQ: OGI) (TSX-V: OGI), CannTrust Holdings Inc. (NYSE: CTST) (TSX: TRST), Aleafia Health Inc (OTCQX: ALEAF) (TSX: ALEF), THC Biomed International (OTCQX: THCBF) (CSE: THC), Cronos Group (NASDAQ: CRON) (TSX: CRON).

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel